HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$157M |
| 2 |
Cognizant
CTSH
|
+$144M |
| 3 |
UnitedHealth
UNH
|
+$125M |
| 4 |
Apple
AAPL
|
+$124M |
| 5 |
Jackson Financial
JXN
|
+$124M |
Top Sells
| 1 |
Pinduoduo
PDD
|
+$255M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$207M |
| 3 |
NVIDIA
NVDA
|
+$173M |
| 4 |
Aramark
ARMK
|
+$170M |
| 5 |
Netflix
NFLX
|
+$155M |
Sector Composition
| 1 | Technology | 26.91% |
| 2 | Financials | 13.14% |
| 3 | Healthcare | 12.48% |
| 4 | Consumer Discretionary | 11.66% |
| 5 | Communication Services | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Karyopharm Therapeutics
KPTI
$54.2M
| $60.4K | ﹤0.01% |
2,995
+2,176
| +266% | +$43.9K |
|
|
SHCR
2102
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $59.9K | ﹤0.01% |
63,061
| – | – |
|
2103
DHI Group
DHX
$143M
| $58.8K | ﹤0.01% |
19,266
+1
| +0% | +$3 |
|
2104
LivePerson
LPSN
$93.7M
| $58.5K | ﹤0.01% |
+14,751
| New | +$58.5K |
|
2105
Nautilus Biotechnolgy
NAUT
$88.5M
| $57.8K | ﹤0.01% |
18,464
| – | – |
|
2106
Rayonier Advanced Materials
RYAM
$403M
| $57.3K | ﹤0.01% |
+16,064
| New | +$57.3K |
|
2107
SGHC Ltd
SGHC
$6.4B
| $56.3K | ﹤0.01% |
+15,733
| New | +$56.3K |
|
2108
Personalis
PSNL
$472M
| $54.6K | ﹤0.01% |
45,465
| – | – |
|
|
ILPT
2109
Industrial Logistics Properties Trust
ILPT
$407M
| $52.5K | ﹤0.01% |
18,527
-1,348
| -7% | -$3.82K |
|
|
LENZ
2110
LENZ Therapeutics
LENZ
$1.13B
| $52.2K | ﹤0.01% |
+3,108
| New | +$52.2K |
|
2111
Allogene Therapeutics
ALLO
$253M
| $50.7K | ﹤0.01% |
+16,155
| New | +$50.7K |
|
2112
Clear Channel Outdoor Holdings
CCO
$681M
| $49.8K | ﹤0.01% |
31,525
+2,980
| +10% | +$4.71K |
|
|
TELL
2113
DELISTED
Tellurian Inc.
TELL
| $48.6K | ﹤0.01% |
41,865
| – | – |
|
|
KRON
2114
DELISTED
Kronos Bio
KRON
| $48.3K | ﹤0.01% |
38,368
| – | – |
|
|
CONN
2115
DELISTED
Conn's Inc.
CONN
| $48.2K | ﹤0.01% |
+12,365
| New | +$48.2K |
|
2116
Riskified
RSKD
$739M
| $48.1K | ﹤0.01% |
+10,708
| New | +$48.1K |
|
2117
Amneal Pharmaceuticals
AMRX
$3.06B
| $47.9K | ﹤0.01% |
+11,433
| New | +$47.9K |
|
2118
FibroGen
FGEN
$45.1M
| $47.1K | ﹤0.01% |
2,171
-958
| -31% | -$20.8K |
|
2119
Nektar Therapeutics
NKTR
$843M
| $45.6K | ﹤0.01% |
5,057
| – | – |
|
2120
Annexon
ANNX
$243M
| $45.2K | ﹤0.01% |
+19,262
| New | +$45.2K |
|
2121
FTAI Infrastructure
FIP
$465M
| $45K | ﹤0.01% |
14,068
-20,798
| -60% | -$66.6K |
|
2122
fuboTV
FUBO
$1.41B
| $42.6K | ﹤0.01% |
+16,053
| New | +$42.6K |
|
|
VNET
2123
VNET Group
VNET
$2.07B
| $40.3K | ﹤0.01% |
12,787
+1,900
| +17% | +$5.99K |
|
|
URG
2124
Ur-Energy
URG
$529M
| $38.9K | ﹤0.01% |
25,000
| – | – |
|
|
ALLK
2125
DELISTED
Allakos
ALLK
| $36.1K | ﹤0.01% |
16,269
-3,163
| -16% | -$7.02K |
|